Results 41 to 50 of about 8,294 (235)
Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free wall): a follow-up study using CMR tissue tagging and 3D strain analysis [PDF]
, 2006 Aims: Alcohol septal ablation (ASA) has been successful in the treatment of symptomatic hypertrophic obstructive cardiomyopathy (HOCM). The aim of this study is to evaluate the effects of ethanol-induced myocardial infarcts on regional myocardial ...
Beek, A.M. +9 more
core +2 more sources
Alcohol septal ablation in hypertrophic cardiomyopathy
Global Cardiology Science and Practice, 2018 Alcohol septal ablation (ASA) has become an alternative to surgical myectomy in obstructive hypertrophic cardiomyopathy since it was first introduced in 1994 by Sigwart. The procedure alleviates symptoms by producing a limited infarction of the upper interventricular septum, resulting in a decrease in left ventricular outflow tract (LVOT) gradient. The
Mateo, Juan José Santos +1 more
openaire +3 more sources
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy [PDF]
Current Cardiology Reviews, 2008 Since its original description in 1994, alcohol septal ablation (ASA) has emerged as a minimally invasive modality for treatment of hypertrophic obstructive cardiomyopathy compared to surgical myomectomy. This catheter-based intervention relies on the injection of absolute alcohol into the septal perforator to induce a controlled infarction of the ...
El Masry, Hicham, Breall, Jeffrey A
openaire +2 more sources
КардиоСоматикаBACKGROUND: Hypertrophic cardiomyopathy is a primarily genetically determined myocardial disease characterized by pronounced, often asymmetric, myocardial hypertrophy that results in diastolic dysfunction and left ventricular outflow tract obstruction ...
Mariia S. Nozdriakova +5 more
doaj +1 more source
TAVI-in-TAVI in a patient after alcohol septal ablation
Advances in Interventional Cardiology, 2021 Cardiovascular medicine at its beginning was dominated by surgical treatment options. The trend of the last decades is heading towards catheterization procedures.
Eva Polaková +3 more
doaj +1 more source
Septal alcoholization in hypertrophic cardiomyopathy: about 11 cases
The Pan African Medical Journal, 2017 Outcomes of septal alcoholization in hypertrophic obstructive cardiomyopathy are not enough studied in all centers. The purpose of this study was to determine the outcomes of septal alcoholization in hypertrophic obstructive cardiomyopathy in our ...
Yibar Kambire +3 more
doaj +1 more source
Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2022 Alcohol septal ablation (ASA) is an effective treatment for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). Although routine use of myocardial contrast echocardiography (MCE) in guiding ASA has been recommended by guidelines, it has not come ...
Sridhar Lakshmana Sastry +4 more
doaj +1 more source
Excess mortality and sex differences in outcome in hypertrophic cardiomyopathy: a European multicentre study [PDF]
, 2019 Background. Contemporary survival studies in hypertrophic cardiomyopathy (HCM) have shown that the prognosis for most individuals with the disease is much better than described previously, but it remains unclear whether HCM conveys an excess mortality ...
Lorenzini, Massimiliano <1983>
core +1 more source
Advanced Functional Materials, EarlyView.Biofabrication aims at providing innovative technologies and tools for the fabrication of tissue‐like constructs for tissue engineering and regenerative medicine applications. By integrating multiple biofabrication technologies, such as 3D (bio) printing with fiber fabrication methods, it would be more realistic to reconstruct native tissue's ...
Waseem Kitana +2 more
wiley +1 more source
Hypertrophic obstructive cardiomyopathy: alcohol septal ablation [PDF]
, 2017 Alcohol septal ablation (ASA) was introduced in 1994 as an alternative to septal myectomy for patients with hypertrophic obstructive cardiomyopathy and symptoms refractory to medical therapy.
Fifer, Michael A., Sigwart, Ulrich
core